10,000-Patient study aims to unlock best of both worlds for arthritis

NCT ID NCT07484243

Recruiting now Knowledge-focused Sponsor: Dongyi He Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 22, 2026 · Updated 3 times

Summary

This large observational study will follow 10,000 people with rheumatoid arthritis (RA) who are receiving a combination of Traditional Chinese Medicine (TCM) and standard Western medicine. Researchers will collect health data and biological samples over time to understand which treatment approaches work best for different patients, including those with difficult-to-treat RA or RA-related lung disease. The goal is to create a more scientific and standardized way to evaluate and improve integrated treatment plans.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Integrated Traditional Chinese and Western Medicine
What this could lead to: If successful, this could lead to better, more personalized treatment strategies for rheumatoid arthritis, especially for hard-to-treat cases and those with lung complications.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may take years and might not lead to immediate new treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rheumatoid arthritis rheumatoid arthritis-associated interstitial lung disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS RHEUMATOID ARTHRITIS (RA) RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE

Contacts and locations

Locations

Shanghai Guanghua Hospital of Integrative Medicine
RECRUITING

Shanghai, 200052, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.